Literature DB >> 6180065

Characteristics of alloantigens and cellular mechanisms responsible for gamma-interferon production in primary murine MLC.

S Landolfo, F Marcucci, V Schirrmacher, H Kirchner.   

Abstract

We have investigated in primary murine MLC alloantigen differences and characteristics of responding cells responsible for gamma-IFN production. Differences at K, D, or I-S-G regions stimulate gamma-IFN release, though higher levels of production have been observed with differences at I-S-G regions. On the other hand, when mice differing in their minor histocompatibility antigens, notably at the MIs locus, were tested, gamma-IFN production took place even between strain combinations not displaying lymphocyte proliferation. Lastly, using different cell depletion techniques, we demonstrate that T-lymphocytes are the cells producing gamma-IFN upon stimulation with alloantigens. These findings show that T lymphocytes can recognize alloantigens by releasing gamma-IFN even without displaying proliferation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6180065     DOI: 10.1089/jir.1981.1.339

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  4 in total

1.  Immune suppression and induction of gamma interferon by pertussis toxin.

Authors:  F R Vogel; T W Klein; W E Stewart; T Igarashi; H Friedman
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

Review 2.  Interferons, a group of multiple lymphokines.

Authors:  H Kirchner
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Monoclonal antibodies against murine gamma interferon.

Authors:  M Prat; G Gribaudo; P M Comoglio; G Cavallo; S Landolfo
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

4.  Encapsulation mechanisms and structural studies of GRM2 bacterial microcompartment particles.

Authors:  Gints Kalnins; Eva-Emilija Cesle; Juris Jansons; Janis Liepins; Anatolij Filimonenko; Kaspars Tars
Journal:  Nat Commun       Date:  2020-01-20       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.